1,290 articles
Session 2 of the Intellectual Property Masterclass by BananaIP and NASSCOM will focus on patents and their relevance for startups. Senior experts will discuss patentability, patent searches, and…
The post offers updated and amended versions of major Indian intellectual property statutes following the abolition of the IPAB. Downloadable resources and detailed amendment summaries are provided for…
The article examines India’s policy on compulsory licensing for COVID-related medical technologies, echoing Prof. Arul Scaria’s critique of current government inaction. It highlights the legal and historical basis…
Natco Pharma has withdrawn its compulsory license application for Baricitinib following an agreement with Eli Lilly. The Indian Patent Office has extended procedural deadlines, and other significant updates…
BananaIP and NASSCOM present a free master class on intellectual property for startups, entrepreneurs, and SMEs. Participants will gain essential insights on protecting and commercializing their innovations, with…
Natco seeks a compulsory license for Baricitinib, while the USA backs a temporary COVID-19 vaccine patent waiver. The EU critiques the US approach, and Ericsson and Samsung resolve…
The Supreme Court has indefinitely extended limitation periods for legal proceedings in view of the COVID-19 situation and questioned the Government's approach to compulsory licensing of essential medicines.…
This post analyses World IP Day amid the COVID-19 pandemic, questioning whether intellectual property systems have supported or hindered access to vital medicines. It highlights the limited measures…
The Delhi High Court has advised the government to consider compulsory licensing of COVID-19 treatments, reflecting the urgent need for wider access. This post also covers the global…
This post provides an analytical overview of recent patent disputes and policy developments. It discusses the Nokia-Lenovo settlement, Apple’s patent damages appeal, and new USPTO initiatives related to…